Cargando…

Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use

BACKGROUND: National health monitoring agencies have reported the alternative use of morphine sulfate painkiller for maintenance treatment of opioid use disorder (OUD), associated with a potential increase in overdose risk. OBJECTIVES: This study sought to assess the prevalence of regular and occasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertin, Célian, Bezin, Julien, Chenaf, Chouki, Delorme, Jessica, Kerckhove, Nicolas, Pariente, Antoine, Tournier, Marie, Authier, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282723/ https://www.ncbi.nlm.nih.gov/pubmed/35845444 http://dx.doi.org/10.3389/fpsyt.2022.893590

Ejemplares similares

Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions
por: Delorme, Jessica, et al.
Publicado: (2018)

Chronic pain is a risk factor for incident Alzheimer’s disease: a nationwide propensity-matched cohort using administrative data
por: Bornier, Nadège, et al.
Publicado: (2023)

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale
por: Kerckhove, Nicolas, et al.
Publicado: (2022)

People who inject oral morphine favor experimentation with injectable opioid substitution
por: Bertin, Célian, et al.
Publicado: (2023)

Opioid Analgesic Prescription in French Children: A National Population-Based Study
por: Choufi, Samira, et al.
Publicado: (2021)

Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients
por: Delorme, Jessica, et al.
Publicado: (2021)

Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care
por: Laporte, Catherine, et al.
Publicado: (2022)

Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected?
por: Bertin, Célian, et al.
Publicado: (2023)

Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT—protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial
por: Kerckhove, Nicolas, et al.
Publicado: (2016)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
por: Pariente, Antoine, et al.
Publicado: (2021)

Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis
por: Mathieu, Clément, et al.
Publicado: (2023)

Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study
por: Bénard-Laribière, Anne, et al.
Publicado: (2022)

A human stem cell-derived neuronal model of morphine exposure reflects brain dysregulation in opioid use disorder: Transcriptomic and epigenetic characterization of postmortem-derived iPSC neurons
por: Mendez, Emily F., et al.
Publicado: (2023)

Risk of PTSD Due to the COVID-19 Pandemic Among Patients in Opioid Substitution Treatment
por: Fuchs-Leitner, Isabella, et al.
Publicado: (2021)

Prevalence of Opioid Use Disorder among Patients with Cancer-Related Pain: A Systematic Review
por: Preux, Céline, et al.
Publicado: (2022)

Sensitivity to Morphine Reward Associates With Gut Dysbiosis in Rats With Morphine-Induced Conditioned Place Preference
por: Zhang, Jingyuan, et al.
Publicado: (2020)

Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study
por: Grall-Bronnec, Marie, et al.
Publicado: (2019)

Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019)

Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2022)

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
por: Greenwald, Mark K., et al.
Publicado: (2023)

Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse
por: Strickland, Justin C., et al.
Publicado: (2022)

Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)

Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery
por: Trakimas, Danielle R., et al.
Publicado: (2022)

Forging Neuroimaging Targets for Recovery in Opioid Use Disorder
por: Stewart, Jennifer L., et al.
Publicado: (2019)

Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
por: Mathieu, Clément, et al.
Publicado: (2022)

Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity
por: Guinchat, Vincent, et al.
Publicado: (2022)

Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice
por: Kakko, Johan, et al.
Publicado: (2019)

A Systematic Review of Opioid Use Disorder and Related Biomarkers
por: Bryant, Bianca M., et al.
Publicado: (2021)

Trends of influenza vaccination coverage in pregnant women: a ten-year analysis from a French healthcare database
por: Corbeau, Mélodie, et al.
Publicado: (2022)

What are the neural correlates of dissociative amnesia? A systematic review of the functional neuroimaging literature
por: Taïb, Simon, et al.
Publicado: (2023)

Network-Based Discovery of Opioid Use Vulnerability in Rats Using the Bayesian Stochastic Block Model
por: Allen, Carter, et al.
Publicado: (2021)

Trends of Opioid Use Disorder and Associated Factors in Hospitalized Patients With Arthritis
por: Oladunjoye, Adeolu O, et al.
Publicado: (2020)

Commentary: Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice
por: Zheng, Rui, et al.
Publicado: (2021)

Editorial: A Changing Epidemic and the Rise of Opioid-Stimulant Co-Use
por: Ahmed, Saeed, et al.
Publicado: (2022)

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
por: Sanger, Nitika, et al.
Publicado: (2020)

MicroRNA–mRNA networks are dysregulated in opioid use disorder postmortem brain: Further evidence for opioid-induced neurovascular alterations
por: Grimm, Sandra L., et al.
Publicado: (2023)

The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis
por: Zangiabadian, Moein, et al.
Publicado: (2022)

The Burden of Potentially Inappropriate Medications in Chronic Polypharmacy
por: Guillot, Jordan, et al.
Publicado: (2020)

Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review
por: Rolland, Benjamin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mji7g03mqs3p7u86thmm5uqlap